{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:28:03Z","timestamp":1781602083890,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Indivior, Inc.,"},{"name":"VRN"},{"name":"SML CH"},{"name":"NAR"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jsat.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T02:19:53Z","timestamp":1573784393000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study"],"prefix":"10.1016","volume":"110","author":[{"given":"Walter","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay R.","family":"Nadipelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn T.","family":"Solem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko A.","family":"Ronquest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Learned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishaal","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heidbreder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2019.11.004_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","article-title":"Opioid use disorder, diagnostic criteria","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1016\/j.jsat.2019.11.004_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5055\/jom.2015.0298","article-title":"Screening for homelessness among individuals initiating medication-assisted treatment for opioid use disorder in the Veterans Health Administration","volume":"11","author":"Bachhuber","year":"2015","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.jsat.2019.11.004_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","article-title":"Quality of life as an outcome of opioid use disorder treatment: A systematic review","volume":"76","author":"Bray","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2019.11.004_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: A review of the literature","volume":"21","author":"De Maeyer","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"16","key":"10.1016\/j.jsat.2019.11.004_bb0025","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.jsat.2019.11.004_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsat.2014.05.002","article-title":"Co-occurring risk factors for arrest among persons with opioid abuse and dependence: Implications for developing interventions to limit criminal justice involvement","volume":"47","author":"Fisher","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2019.11.004_bb0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1377\/hlthaff.2011.0003","article-title":"Informing and involving patients to improve the quality of medical decisions","volume":"30","author":"Fowler","year":"2011","journal-title":"Health affairs (Project Hope)"},{"issue":"10173","key":"10.1016\/j.jsat.2019.11.004_bb0040","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsat.2019.11.004_bb0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2019.11.004_bb0050","doi-asserted-by":"crossref","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., \u2026 Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research: an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 20(10), 1727\u20131736. doi:https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","DOI":"10.1007\/s11136-011-9903-x"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.004_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/SAR.S38902","article-title":"The treatment effectiveness assessment (TEA): An efficient, patient-centered instrument for evaluating progress in recovery from addiction","volume":"3","author":"Ling","year":"2012","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.jsat.2019.11.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000517","article-title":"Patient-centered outcomes in participants of a buprenorphine monthly depot (BUP-XR) double-blind, placebo-controlled, multicenter, phase 3 study","author":"Ling","year":"2019","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2019.11.004_bb0065","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.004_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index","volume":"168","author":"McLellan","year":"1980","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.004_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-019-0296-4","article-title":"Prolonged-release opioid agonist therapy: Qualitative study exploring patients\u2019 views of 1-week, 1-month, and 6-month buprenorphine formulations","volume":"16","author":"Neale","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.jsat.2019.11.004_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drugalcdep.2015.10.009","article-title":"Short term health-related quality of life improvement during opioid agonist treatment","volume":"157","author":"Nosyk","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.jsat.2019.11.004_bb0085","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s11136-011-0027-0","article-title":"Health-related quality of life changes associated with buprenorphine treatment for opioid dependence","volume":"21","author":"Raisch","year":"2012","journal-title":"Quality of Life Research"},{"key":"10.1016\/j.jsat.2019.11.004_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/SAR.S150253","article-title":"Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder","volume":"9","author":"Ronquest","year":"2018","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.jsat.2019.11.004_bb0095","first-page":"1","article-title":"Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder","author":"Stein","year":"2017","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2019.11.004_bb0100","series-title":"SUBLOCADE [package insert]","year":"2018"},{"issue":"1","key":"10.1016\/j.jsat.2019.11.004_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.schres.2010.01.021","article-title":"Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients","volume":"118","author":"Vernon","year":"2010","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2019.11.004_bb0110","series-title":"User\u2019s manual for the SF-36v2 health survey","author":"Ware","year":"2008"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:31Z","timestamp":1760039431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219301680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":22,"alternative-id":["S0740547219301680"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.004","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}